Cowen Reiterates Outperform Rating, $12 PT on Ginkgo Bioworks Holdings Inc (DNA) Following Earnings
Tweet Send to a Friend
Cowen analyst Steven Mah reiterated an Outperform rating and $12.00 price target on Ginkgo Bioworks Holdings Inc (NYSE: DNA), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
